AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. STXS
  4. [424B5] Stereotaxis, Inc. Prospectus Supplement (Debt Securities)

[424B5] Stereotaxis, Inc. Prospectus Supplement (Debt Securities)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
424B5
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock STXS logo
Stereotaxis Ord

NYSE:STXS

STXS Rankings

#5826 Ranked by Market Cap
N/A Ranked by Dividends

STXS Latest News

Aug 7, 2025
Stereotaxis Reports 2025 Second Quarter Financial Results
Jul 28, 2025
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
Jul 23, 2025
Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025
Jul 17, 2025
Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock
Jul 1, 2025
First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

STXS Latest SEC Filings

Aug 7, 2025
[8-K] Stereotaxis, Inc. Reports Material Event
Jul 17, 2025
[8-K] Stereotaxis, Inc. Reports Material Event
Jul 17, 2025
[8-K] Stereotaxis, Inc. Reports Material Event
Jul 3, 2025
[Form 4] Stereotaxis, Inc. Insider Trading Activity
Jul 3, 2025
[Form 4] Stereotaxis, Inc. Insider Trading Activity

STXS Stock Data

202.16M
60.54M
29.61%
44.31%
4.58%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
United States
ST.LOUIS